Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.14
Delayed Data
As of 4:00pm ET
 -0.06 / -2.73%
Today’s Change
1.81
Today|||52-Week Range
3.35
+3.38%
Year-to-Date
Geron (GERN) Q4 Earnings: What's in Store for the Stock?
Feb 17 / Zacks.com - Paid Partner Content
4 Stocks Under $4 That Could Double
Feb 09 / MotleyFool.com - Paid Partner Content
No Joke: Johnson & Johnson Could Grow Sales by 5% (or More) Annually Over the Next De...
Feb 15 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close2.20
Today’s open2.29
Day’s range2.13 - 2.25
Volume859,568
Average volume (3 months)1,380,342
Market cap$350.1M
Dividend yield--
Data as of 4:00pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,054.47%
P/E ratioNM
Price/Sales21.65
Price/Book2.46

Competitors

 Today’s
change
Today’s
% change
BTXBioTime Inc+0.02+0.63%
BOLDAudentes Therapeutic...-1.20-7.23%
BLCMBellicum Pharmaceuti...-0.60-4.48%
VYGRVoyager Therapeutics...0.000.00%
Data as of 4:01pm ET, 02/22/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$36.4M
Annual profit (last year)$46.0K
Net profit margin0.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs